Polen Capital Repligen Corp Transaction History
Polen Capital Management LLC
- $37 Billion
- Q4 2024
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Repligen Corp stock. As of the latest transaction made, Polen Capital Management LLC holds 40,556 shares of RGEN stock, worth $6.55 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,556
Previous 35,383
14.62%
Holding current value
$6.55 Million
Previous $5.27 Million
10.86%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.22 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.15 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$824 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$273 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$249 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.96B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....